Compare BIO-TECHNE Corp (TECH) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Energy Select Sector SPDR Fund — how do they compare? BIO-TECHNE Corp trades at $72.13 (market cap $11.24B), while Energy Select Sector SPDR Fund trades at $60.88. The key difference: BIO-TECHNE Corp pays a 0.44% dividend while Energy Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| TECH | XLE | |
|---|---|---|
Market Cap | $11.24B | — |
Sector | Health | — |
52-Week High | $72.29 | $62.57 |
52-Week Low | $43.31 | $42.12 |
Enterprise Value | $11.32B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
XLE (Energy Select Sector SPDR ETF) trades at $57.48, down 1.17% amid bearish technical signals. The ETF faces headwinds despite strong energy sector performance driven by geopolitical tensions and elevated oil prices. Recent earnings from major holdings like ExxonMobil and Chevron showed profit surges, but technical indicators suggest near-term weakness with resistance at $58 and support at $57.
Outlook remains mixed with geopolitical risks supporting oil prices but technical weakness suggesting caution. The concentrated exposure to major energy companies provides stability but limits diversification. Key risks include oil price volatility and Middle East tensions, while the low expense ratio of 0.08% maintains cost efficiency for long-term energy exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
